EULAR-PReS points to consider for the use of imaging in the diagnosis and management of juvenile idiopathic arthritis in clinical practice
Alexandra N. Colebatch-Bourn(Yeovil District Hospital NHS Foundation Trust), Clara Malattia(Istituto Giannina Gaslini), Alberto Martini(Agenzia Regionale Prevenzione e Ambiente della Regione Emilia-Romagna), Madeleine Rooney(Queen's University Belfast), Mario Maas(Amsterdam UMC Location University of Amsterdam), Nikolay Tzaribachev(University of Amsterdam), Mette V. Østergaard(University of Southern Denmark), Sandrine Jousse‐Joulin(Inserm), Jelena Vojinović(University of Nis), Esperanza Naredo(Hospital Universitario Fundación Jiménez Díaz), Robert Hemke(Amsterdam University Medical Centers), Christopher J Edwards(University Hospital Southampton NHS Foundation Trust), Maria Antonietta D’Agostino(Agostino Gemelli University Polyclinic), Philip G. Conaghan(University of Leeds), Marion A. van Rossum(Reade), Paz Collado(Hospital Universitario Severo Ochoa)
Cited by 160
Related Papers
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
|Annals of the Rheumatic Diseases|2020|2.8k
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update
|Annals of the Rheumatic Diseases|2022|1.9k
2022 update
|Radboud Repository (Radboud University)|2010|1.6k
EULAR recommendations for the non-pharmacological core management of hip and knee osteoarthritis
|Annals of the Rheumatic Diseases|2013|1.4k